ATF6
Cyclic AMP-dependent transcription factor ATF-6 alpha
Also known as: ATF6A, ATF6A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P18850
- Gene
- ATF6
- Ensembl
- ENSG00000118217
- Chromosome
- 1
- Canonical length
- 670 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a transcription factor that activates target genes for the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Although it is a transcription factor, this protein is unusual in that it is synthesized as a transmembrane protein that is embedded in the ER. It functions as an ER stress sensor/transducer, and following ER stress-induced proteolysis, it functions as a nuclear transcription factor via a cis-acting ER stress response element (ERSE) that is present in the promoters of genes encoding ER chaperones. This protein has been identified as a survival factor for quiescent but not proliferative squamous carcinoma cells. There have been conflicting reports about the association of polymorphisms in this gene with diabetes in different populations, but another polymorphism has been associated with increased plasma cholesterol levels. This gene is also thought to be a potential therapeutic target for cystic fibrosis. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
670 residues, UniProt reviewed canonical sequence.
>P18850|ATF6
1 MGEPAGVAGT MESPFSPGLF HRLDEDWDSA LFAELGYFTD TDELQLEAAN ETYENNFDNL
61 DFDLDLMPWE SDIWDINNQI CTVKDIKAEP QPLSPASSSY SVSSPRSVDS YSSTQHVPEE
121 LDLSSSSQMS PLSLYGENSN SLSSAEPLKE DKPVTGPRNK TENGLTPKKK IQVNSKPSIQ
181 PKPLLLPAAP KTQTNSSVPA KTIIIQTVPT LMPLAKQQPI ISLQPAPTKG QTVLLSQPTV
241 VQLQAPGVLP SAQPVLAVAG GVTQLPNHVV NVVPAPSANS PVNGKLSVTK PVLQSTMRNV
301 GSDIAVLRRQ QRMIKNRESA CQSRKKKKEY MLGLEARLKA ALSENEQLKK ENGTLKRQLD
361 EVVSENQRLK VPSPKRRVVC VMIVLAFIIL NYGPMSMLEQ DSRRMNPSVS PANQRRHLLG
421 FSAKEAQDTS DGIIQKNSYR YDHSVSNDKA LMVLTEEPLL YIPPPPCQPL INTTESLRLN
481 HELRGWVHRH EVERTKSRRM TNNQQKTRIL QGALEQGSNS QLMAVQYTET TSSISRNSGS
541 ELQVYYASPR SYQDFFEAIR RRGDTFYVVS FRRDHLLLPA TTHNKTTRPK MSIVLPAINI
601 NENVINGQDY EVMMQIDCQV MDTRILHIKS SSVPPYLRDQ QRNQTNTFFG SPPAATEATH
661 VVSTIPESLQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATF6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.65
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 33 nTPM
- liver: 21 nTPM
- epididymis: 18 nTPM
- parathyroid gland: 18 nTPM
- placenta: 17 nTPM
- retina: 15 nTPM
Single-cell type
- neutrophils: 904 nCPM
- breast hormone-responsive cells: 402 nCPM
- monocytes: 389 nCPM
- macrophages: 361 nCPM
- alveolar cells type 2: 298 nCPM
- microglia: 297 nCPM
Immune cell
- neutrophil: 34 nTPM
- non-classical monocyte: 25 nTPM
- intermediate monocyte: 18 nTPM
- classical monocyte: 18 nTPM
- myeloid DC: 13 nTPM
- eosinophil: 12 nTPM
Brain region
- choroid plexus: 38 nTPM
- white matter: 35 nTPM
- medulla oblongata: 32 nTPM
- hypothalamus: 31 nTPM
- spinal cord: 31 nTPM
- midbrain: 30 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATF6.
Disease | AllUniProt
Conditions ATF6 is implicated in, by any mechanism.
- Achromatopsia 7 (ACHM7) MIM:616517
Disease | GeneticClinVar
46 pathogenic / likely-pathogenic of 516 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Achromatopsia 7
- Achromatopsia
- Retinal dystrophy
- Bilateral sensorineural hearing impairment
- ATF6-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.56
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ATF6-mediated unfolded protein response
- endoplasmic reticulum unfolded protein response
- ERAD pathway
- eye development
- positive regulation of apoptotic process
- positive regulation of autophagy
- positive regulation of transcription by RNA polymerase II
- protein folding
- regulation of transcription by RNA polymerase II
- response to endoplasmic reticulum stress
- signal transduction
- visual perception
- positive regulation of ATF6-mediated unfolded protein response
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- enzyme binding
- identical protein binding
- protein heterodimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- transcription cis-regulatory region binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATF6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATF6 as an antibody target. Whether an autoantibody or antibody against ATF6 could matter depends on whether native ATF6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATF6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATF6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...